Rigel Pharmaceuticals | 销售和管理费用





销售和管理费用 更改 日
Agenus USD 23.6M 448K 2025-09
Amgen USD 1.94B 237M 2025-12
Anika Therapeutics USD 12.91M 17.8M 2025-03
Arrowhead Research USD 46.02M 8.84M 2025-12
AstraZeneca USD 148M 4.86B 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celldex Therapeutics USD 6.63M 546K 2025-09
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Heron Therapeutics USD 23.34M 4.18M 2024-09
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
MacroGenics USD 9.9M 600K 2025-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Veracyte USD 51.73M 5.91M 2025-09


Rigel Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.